Every other month DMRF Canada publishes Going Forward; our bi-monthly e-newsletter.
What's Making News
Stefanie Ince, Executive Director of the Dystonia Medical Research Foundation was on hand to speak to 680 News about the challenges associated with living with dystonia – and why funding research to find a cure is so critical. As the largest radio newsroom in Canada, 680 News averages 1 million listeners across the GTA every 10 minutes.
Hear Stefanie’s interview here:
Those in attendance at September’s Kelowna Okanagan Dystonia Support Group meeting included (from left) N
DMRF Canada is pleased to announce the launch of an annual one-year clinical fellowship to support the training of exceptionally qualified physicians in preparation for their clinical career in movement disorders with a focus on dystonia and a special competence in use of botulinum toxins. In 2017, this program will support fellows through a grant from Allergan.
According to the research, the childhood-onset motor disorder DYT6 dystonia is caused by loss-of-function mutations in the transcription factor THAP1, but the neurodevelopmental processes in which THAP1 participates are unknown.